Burn and Scald Medicine Market to Reach $6.36 Billion by 2031, Growing at a 5.0% CAGR (2025-2031)

LOS ANGELES, United States: The global Burn and Scald Medicine Market is witnessing significant growth, driven by increasing cases of burns due to accidents, industrial hazards, and aging populations. The integration of biotechnology and nanotechnology in burn treatments is further revolutionizing the industry, offering advanced healing solutions.

Market Overview

According to QYResearch, the market was valued at $4.52 billion in 2024 and is expected to reach $6.36 billion by 2031, growing at a CAGR of 5.0%. With rising awareness and government-backed healthcare initiatives, the demand for effective burn and scald treatments is expanding globally.

To get a sample or know more, please do click on the below link: https://www.qyresearch.in/request-sample/pharma-healthcare-global-burn-and-scald-medicine-market-research-report-2025

Key Market Drivers

1. Rising Incidence of Burns & Scalds: Urbanization, industrial expansion, and domestic accidents have led to an increasing number of burn injuries, escalating the demand for effective treatments.

2. Medical Advancements: The application of biotechnology and nanotechnology is enhancing burn healing processes, driving market expansion.

3. Government Policies & Awareness Campaigns: Policies ensuring 70-100% treatment coverage and support from global organizations like the WHO and ABA are improving burn care facilities and accessibility.

4. Innovation in Treatment Options: Growth factors, skin regeneration therapies, and advanced wound care solutions are shaping the future of the market.

Market Segmentation

By Product Type:

Dressing
Ointment
Spray

By Application:

Hospital
Clinic
Pharmacy
Online

Competitive Landscape

Leading players in the market include Mebao Pharmaceutical Technology Group, B. Braun, Integra LifeSciences, Smith & Nephew, and Yangtze River Pharmaceutical Group. In 2023, the top 10 players accounted for approximately 49% of global revenue, highlighting a moderately consolidated market with significant competition.

Trends & Opportunities

(A) Rise in Home-based Treatments: Increasing availability of over-the-counter burn treatment products is making home-based care more prevalent.

(B) Technological Innovations: Development of smart wound dressings and bioengineered skin substitutes are emerging trends in burn treatment.

(C) Expanding Online Pharmacies: Digital healthcare platforms are enhancing accessibility to burn medications worldwide.

(D) Regional Growth Potential: Asia-Pacific is emerging as a lucrative market due to growing healthcare investments and increased burn incidents in industrial settings.

Conclusion

The Burn and Scald Medicine Market is set for steady growth, supported by technological advancements, increasing burn cases, and government initiatives promoting better healthcare access. With innovation in drug development and improved treatment methods, the industry is poised for transformation in the coming years.

For in-depth insights, Market Segmentation, and Detailed Competitor Analysis, Refer to the Full Report Please Visit: https://www.qyresearch.in/report-details/0718456/Global-Burn-and-Scald-Medicine-Market

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Burn and Scald Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Dressing
1.2.3 Ointment
1.2.4 Spray
1.3 Market by Application
1.3.1 Global Burn and Scald Medicine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Online
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Burn and Scald Medicine Market Perspective (2020-2031)
2.2 Global Burn and Scald Medicine Growth Trends by Region
2.2.1 Global Burn and Scald Medicine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Burn and Scald Medicine Historic Market Size by Region (2020-2025)
2.2.3 Burn and Scald Medicine Forecasted Market Size by Region (2026-2031)
2.3 Burn and Scald Medicine Market Dynamics
2.3.1 Burn and Scald Medicine Industry Trends
2.3.2 Burn and Scald Medicine Market Drivers
2.3.3 Burn and Scald Medicine Market Challenges
2.3.4 Burn and Scald Medicine Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Burn and Scald Medicine Players by Revenue
3.1.1 Global Top Burn and Scald Medicine Players by Revenue (2020-2025)
3.1.2 Global Burn and Scald Medicine Revenue Market Share by Players (2020-2025)
3.2 Global Top Burn and Scald Medicine Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Burn and Scald Medicine Revenue
3.4 Global Burn and Scald Medicine Market Concentration Ratio
3.4.1 Global Burn and Scald Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Burn and Scald Medicine Revenue in 2024
3.5 Global Key Players of Burn and Scald Medicine Head office and Area Served
3.6 Global Key Players of Burn and Scald Medicine, Product and Application
3.7 Global Key Players of Burn and Scald Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans

4 Burn and Scald Medicine Breakdown Data by Type
4.1 Global Burn and Scald Medicine Historic Market Size by Type (2020-2025)
4.2 Global Burn and Scald Medicine Forecasted Market Size by Type (2026-2031)

5 Burn and Scald Medicine Breakdown Data by Application
5.1 Global Burn and Scald Medicine Historic Market Size by Application (2020-2025)
5.2 Global Burn and Scald Medicine Forecasted Market Size by Application (2026-2031)

6 North America
6.1 North America Burn and Scald Medicine Market Size (2020-2031)
6.2 North America Burn and Scald Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Burn and Scald Medicine Market Size by Country (2020-2025)
6.4 North America Burn and Scald Medicine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada

7 Europe
7.1 Europe Burn and Scald Medicine Market Size (2020-2031)
7.2 Europe Burn and Scald Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Burn and Scald Medicine Market Size by Country (2020-2025)
7.4 Europe Burn and Scald Medicine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries

8 Asia-Pacific
8.1 Asia-Pacific Burn and Scald Medicine Market Size (2020-2031)
8.2 Asia-Pacific Burn and Scald Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Burn and Scald Medicine Market Size by Region (2020-2025)
8.4 Asia-Pacific Burn and Scald Medicine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia

9 Latin America
9.1 Latin America Burn and Scald Medicine Market Size (2020-2031)
9.2 Latin America Burn and Scald Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Burn and Scald Medicine Market Size by Country (2020-2025)
9.4 Latin America Burn and Scald Medicine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Burn and Scald Medicine Market Size (2020-2031)
10.2 Middle East & Africa Burn and Scald Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Burn and Scald Medicine Market Size by Country (2020-2025)
10.4 Middle East & Africa Burn and Scald Medicine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE

11 Key Players Profiles
11.1 Nipro
11.1.1 Nipro Company Details
11.1.2 Nipro Business Overview
11.1.3 Nipro Burn and Scald Medicine Introduction
11.1.4 Nipro Revenue in Burn and Scald Medicine Business (2020-2025)
11.1.5 Nipro Recent Development
11.2 MediWound
11.2.1 MediWound Company Details
11.2.2 MediWound Business Overview
11.2.3 MediWound Burn and Scald Medicine Introduction
11.2.4 MediWound Revenue in Burn and Scald Medicine Business (2020-2025)
11.2.5 MediWound Recent Development
11.3 STADA Arzneimittel
11.3.1 STADA Arzneimittel Company Details
11.3.2 STADA Arzneimittel Business Overview
11.3.3 STADA Arzneimittel Burn and Scald Medicine Introduction
11.3.4 STADA Arzneimittel Revenue in Burn and Scald Medicine Business (2020-2025)
11.3.5 STADA Arzneimittel Recent Development
11.4 Elastoplast
11.4.1 Elastoplast Company Details
11.4.2 Elastoplast Business Overview
11.4.3 Elastoplast Burn and Scald Medicine Introduction
11.4.4 Elastoplast Revenue in Burn and Scald Medicine Business (2020-2025)
11.4.5 Elastoplast Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Burn and Scald Medicine Introduction
11.5.4 Pfizer Revenue in Burn and Scald Medicine Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 Bharat Biotech
11.6.1 Bharat Biotech Company Details
11.6.2 Bharat Biotech Business Overview
11.6.3 Bharat Biotech Burn and Scald Medicine Introduction
11.6.4 Bharat Biotech Revenue in Burn and Scald Medicine Business (2020-2025)
11.6.5 Bharat Biotech Recent Development
11.7 Paul Hartmann
11.7.1 Paul Hartmann Company Details
11.7.2 Paul Hartmann Business Overview
11.7.3 Paul Hartmann Burn and Scald Medicine Introduction
11.7.4 Paul Hartmann Revenue in Burn and Scald Medicine Business (2020-2025)
11.7.5 Paul Hartmann Recent Development
11.8 Ono Pharmaceutical
11.8.1 Ono Pharmaceutical Company Details
11.8.2 Ono Pharmaceutical Business Overview
11.8.3 Ono Pharmaceutical Burn and Scald Medicine Introduction
11.8.4 Ono Pharmaceutical Revenue in Burn and Scald Medicine Business (2020-2025)
11.8.5 Ono Pharmaceutical Recent Development
11.9 Centaur Pharmaceuticals
11.9.1 Centaur Pharmaceuticals Company Details
11.9.2 Centaur Pharmaceuticals Business Overview
11.9.3 Centaur Pharmaceuticals Burn and Scald Medicine Introduction
11.9.4 Centaur Pharmaceuticals Revenue in Burn and Scald Medicine Business (2020-2025)
11.9.5 Centaur Pharmaceuticals Recent Development
11.10 Kedrion Biopharma
11.10.1 Kedrion Biopharma Company Details
11.10.2 Kedrion Biopharma Business Overview
11.10.3 Kedrion Biopharma Burn and Scald Medicine Introduction
11.10.4 Kedrion Biopharma Revenue in Burn and Scald Medicine Business (2020-2025)
11.10.5 Kedrion Biopharma Recent Development
11.11 Smith & Nephew
11.11.1 Smith & Nephew Company Details
11.11.2 Smith & Nephew Business Overview
11.11.3 Smith & Nephew Burn and Scald Medicine Introduction
11.11.4 Smith & Nephew Revenue in Burn and Scald Medicine Business (2020-2025)
11.11.5 Smith & Nephew Recent Development
11.12 ConvaTec
11.12.1 ConvaTec Company Details
11.12.2 ConvaTec Business Overview
11.12.3 ConvaTec Burn and Scald Medicine Introduction
11.12.4 ConvaTec Revenue in Burn and Scald Medicine Business (2020-2025)
11.12.5 ConvaTec Recent Development
11.13 B. Braun Melsungen
11.13.1 B. Braun Melsungen Company Details
11.13.2 B. Braun Melsungen Business Overview
11.13.3 B. Braun Melsungen Burn and Scald Medicine Introduction
11.13.4 B. Braun Melsungen Revenue in Burn and Scald Medicine Business (2020-2025)
11.13.5 B. Braun Melsungen Recent Development
11.14 Coloplast
11.14.1 Coloplast Company Details
11.14.2 Coloplast Business Overview
11.14.3 Coloplast Burn and Scald Medicine Introduction
11.14.4 Coloplast Revenue in Burn and Scald Medicine Business (2020-2025)
11.14.5 Coloplast Recent Development
11.15 Mölnlycke Health Care
11.15.1 Mölnlycke Health Care Company Details
11.15.2 Mölnlycke Health Care Business Overview
11.15.3 Mölnlycke Health Care Burn and Scald Medicine Introduction
11.15.4 Mölnlycke Health Care Revenue in Burn and Scald Medicine Business (2020-2025)
11.15.5 Mölnlycke Health Care Recent Development
11.16 Medline Industries
11.16.1 Medline Industries Company Details
11.16.2 Medline Industries Business Overview
11.16.3 Medline Industries Burn and Scald Medicine Introduction
11.16.4 Medline Industries Revenue in Burn and Scald Medicine Business (2020-2025)
11.16.5 Medline Industries Recent Development
11.17 Hartmann
11.17.1 Hartmann Company Details
11.17.2 Hartmann Business Overview
11.17.3 Hartmann Burn and Scald Medicine Introduction
11.17.4 Hartmann Revenue in Burn and Scald Medicine Business (2020-2025)
11.17.5 Hartmann Recent Development
11.18 Ferndale Pharmaceuticals
11.18.1 Ferndale Pharmaceuticals Company Details
11.18.2 Ferndale Pharmaceuticals Business Overview
11.18.3 Ferndale Pharmaceuticals Burn and Scald Medicine Introduction
11.18.4 Ferndale Pharmaceuticals Revenue in Burn and Scald Medicine Business (2020-2025)
11.18.5 Ferndale Pharmaceuticals Recent Development
11.19 Guizhou Jingcheng Medicine
11.19.1 Guizhou Jingcheng Medicine Company Details
11.19.2 Guizhou Jingcheng Medicine Business Overview
11.19.3 Guizhou Jingcheng Medicine Burn and Scald Medicine Introduction
11.19.4 Guizhou Jingcheng Medicine Revenue in Burn and Scald Medicine Business (2020-2025)
11.19.5 Guizhou Jingcheng Medicine Recent Development
11.20 Mebo Pharmaceutical Technology
11.20.1 Mebo Pharmaceutical Technology Company Details
11.20.2 Mebo Pharmaceutical Technology Business Overview
11.20.3 Mebo Pharmaceutical Technology Burn and Scald Medicine Introduction
11.20.4 Mebo Pharmaceutical Technology Revenue in Burn and Scald Medicine Business (2020-2025)
11.20.5 Mebo Pharmaceutical Technology Recent Development
11.21 Shanghai Tenry Pharm
11.21.1 Shanghai Tenry Pharm Company Details
11.21.2 Shanghai Tenry Pharm Business Overview
11.21.3 Shanghai Tenry Pharm Burn and Scald Medicine Introduction
11.21.4 Shanghai Tenry Pharm Revenue in Burn and Scald Medicine Business (2020-2025)
11.21.5 Shanghai Tenry Pharm Recent Development
11.22 Guilin Huanuo Gene Pharmaceutical
11.22.1 Guilin Huanuo Gene Pharmaceutical Company Details
11.22.2 Guilin Huanuo Gene Pharmaceutical Business Overview
11.22.3 Guilin Huanuo Gene Pharmaceutical Burn and Scald Medicine Introduction
11.22.4 Guilin Huanuo Gene Pharmaceutical Revenue in Burn and Scald Medicine Business (2020-2025)
11.22.5 Guilin Huanuo Gene Pharmaceutical Recent Development
11.23 Shanghai Haohai Biotechnology
11.23.1 Shanghai Haohai Biotechnology Company Details
11.23.2 Shanghai Haohai Biotechnology Business Overview
11.23.3 Shanghai Haohai Biotechnology Burn and Scald Medicine Introduction
11.23.4 Shanghai Haohai Biotechnology Revenue in Burn and Scald Medicine Business (2020-2025)
11.23.5 Shanghai Haohai Biotechnology Recent Development
11.24 Beijing SL Pharmaceutical
11.24.1 Beijing SL Pharmaceutical Company Details
11.24.2 Beijing SL Pharmaceutical Business Overview
11.24.3 Beijing SL Pharmaceutical Burn and Scald Medicine Introduction
11.24.4 Beijing SL Pharmaceutical Revenue in Burn and Scald Medicine Business (2020-2025)
11.24.5 Beijing SL Pharmaceutical Recent Development
11.25 Hubei Mayinglong Pharmaceutical
11.25.1 Hubei Mayinglong Pharmaceutical Company Details
11.25.2 Hubei Mayinglong Pharmaceutical Business Overview
11.25.3 Hubei Mayinglong Pharmaceutical Burn and Scald Medicine Introduction
11.25.4 Hubei Mayinglong Pharmaceutical Revenue in Burn and Scald Medicine Business (2020-2025)
11.25.5 Hubei Mayinglong Pharmaceutical Recent Development
11.26 Jianmin Group
11.26.1 Jianmin Group Company Details
11.26.2 Jianmin Group Business Overview
11.26.3 Jianmin Group Burn and Scald Medicine Introduction
11.26.4 Jianmin Group Revenue in Burn and Scald Medicine Business (2020-2025)
11.26.5 Jianmin Group Recent Development
11.27 Tianjin Pharm Group
11.27.1 Tianjin Pharm Group Company Details
11.27.2 Tianjin Pharm Group Business Overview
11.27.3 Tianjin Pharm Group Burn and Scald Medicine Introduction
11.27.4 Tianjin Pharm Group Revenue in Burn and Scald Medicine Business (2020-2025)
11.27.5 Tianjin Pharm Group Recent Development
11.28 Cardinal Health
11.28.1 Cardinal Health Company Details
11.28.2 Cardinal Health Business Overview
11.28.3 Cardinal Health Burn and Scald Medicine Introduction
11.28.4 Cardinal Health Revenue in Burn and Scald Medicine Business (2020-2025)
11.28.5 Cardinal Health Recent Development
11.29 Integra LifeSciences
11.29.1 Integra LifeSciences Company Details
11.29.2 Integra LifeSciences Business Overview
11.29.3 Integra LifeSciences Burn and Scald Medicine Introduction
11.29.4 Integra LifeSciences Revenue in Burn and Scald Medicine Business (2020-2025)
11.29.5 Integra LifeSciences Recent Development
11.30 Deroyal
11.30.1 Deroyal Company Details
11.30.2 Deroyal Business Overview
11.30.3 Deroyal Burn and Scald Medicine Introduction
11.30.4 Deroyal Revenue in Burn and Scald Medicine Business (2020-2025)
11.30.5 Deroyal Recent Development
11.31 DermaRite Industries
11.31.1 DermaRite Industries Company Details
11.31.2 DermaRite Industries Business Overview
11.31.3 DermaRite Industries Burn and Scald Medicine Introduction
11.31.4 DermaRite Industries Revenue in Burn and Scald Medicine Business (2020-2025)
11.31.5 DermaRite Industries Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

About QY Research:

Founded in California, USA, in 2007, QY Research is a globally recognized market research and consulting firm with over 18 years of expertise. With professional teams located in key cities worldwide, we specialize in management consulting, database services, IPO consulting, industry chain analysis, and tailored research solutions. Trusted by over 60,000 clients across five continents, our research and insights are frequently cited in prospectuses, annual reports, and industry presentations. We are committed to delivering data-driven intelligence, innovative strategies, and actionable insights to help businesses make informed decisions.

Contact US

QY RESEARCH, INC.
17890 CASTLETON STREET
SUITE 369, CITY OF INDUSTRY
CA - 91748, UNITED STATES OF AMERICA
Web - https://www.qyresearch.in
Tel: +91-8669986909
Email- ankit@qyresearch.com

This release was published on openPR.